Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

11084	Companies
243306	Keywords
171464	Articles
131024	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 06/12/2024 at 14:30, 2 years 3 months ago

Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug Crofelemer on or Before July 23, 2024
Jaguar Health, Inc. to discuss updates on cancer supportive care portfolio in investor webcast, focusing on CTD and oral mucositis. Details on pivotal phase 3 OnTarget trial for crofelemer

Investor Webcast Jaguar Health Inc. Oral Mucositis Cancer Supportive Care CTD
BRIEF

published on 06/07/2024 at 22:20, 2 years 3 months ago

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Restricted Stock Units Compensation Nasdaq Jaguar Health
BRIEF

published on 06/07/2024 at 22:20, 2 years 3 months ago

Jaguar Health annonce une nouvelle subvention d'incitation aux employés en vertu de la règle d'inscription au Nasdaq 5635(c)(4)

Compensation Nasdaq Unités D'actions Restreintes Santé Jaguar
PRESS RELEASE

published on 06/07/2024 at 22:15, 2 years 3 months ago

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jaguar Health, Inc. granted 1,111 RSUs to a new employee, subject to one-year vesting. The RSUs were approved by the Compensation Committee

Restricted Stock Units Employee Benefits Jaguar Health Inc. RSUs Compensation Committee
BRIEF

published on 05/29/2024 at 14:35, 2 years 3 months ago

Jaguar Health Executes Out-License Deal for Botanical Drug Candidate for Schizophrenia

Jaguar Health Magdalena Biosciences Schizophrenia Botanical Drug Out-License Deal
BRIEF

published on 05/29/2024 at 14:35, 2 years 3 months ago

Jaguar Health conclut un accord de licence pour un médicament botanique candidat contre la schizophrénie

Magdalena Biosciences Schizophrénie Santé Jaguar Accord De Licence Drogue Botanique
PRESS RELEASE

published on 05/29/2024 at 14:30, 2 years 3 months ago

Jaguar Health Executes Out-License Deal with Joint Venture Magdalena Biosciences for Botanical Drug Candidate for Schizophrenia
Jaguar announces expansion of out-licensing agreement with Magdalena Biosciences for Botanical Drug Candidate targeting schizophrenia market. Company to present at Lytham Partners Spring 2024 Investor Conference

Jaguar Health Magdalena Biosciences Lytham Partners Spring 2024 Investor Conference Out-licensing Agreement Schizophrenia Market
BRIEF

published on 05/28/2024 at 14:35, 2 years 3 months ago

Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea

Napo Pharmaceuticals Crofelemer Jaguar Health Study Results Functional Diarrhea
BRIEF

published on 05/28/2024 at 14:35, 2 years 3 months ago

L'essai lancé par un enquêteur sur le Crofelemer de Jaguar Health donne des résultats positifs pour la diarrhée fonctionnelle

Crofelemer Santé Jaguar Napo Pharmaceutique Diarrhée Fonctionnelle Résultats De L'étude
PRESS RELEASE

published on 05/28/2024 at 14:30, 2 years 3 months ago

Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency

Napo Pharmaceuticals Crofelemer Functional Diarrhea Plant-based Prescription Drug Abdominal Pain

Accesswire

Published on 09/26/2026 at 01:00, 1 day 22 hours ago

Guanajuato Silver Renews Base Shelf Prospectus
Published on 09/26/2026 at 01:00, 1 day 22 hours ago

Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 1 hour ago

Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 6 hours ago

Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 8 hours ago

HM Exploration Provides Program Update for the Lewis Pilley's Project

View all ACCESSWIRE

EQS Group

Published on 09/27/2026 at 17:05, 6 hours 39 minutes ago

Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 8 hours ago

QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 8 hours ago

QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 8 hours ago

Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 15 hours ago

Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe

Les Echos

Published on 09/26/2026 at 07:00, 1 day 16 hours ago

Groupe DLSI - Résultat 1er semestre 2026
Published on 09/25/2026 at 18:00, 2 days 5 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 18:00, 2 days 5 hours ago

COGRA : RAPPORT FINANCIER ANNUEL 2025/26
Published on 09/25/2026 at 17:45, 2 days 5 hours ago

COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 6 hours ago

Availability of the 2026 half-year financial report

View all LES ECHOS COMFI WIRE